Fisher & Paykel Healthcare launches revolutionary F&P SoloTM Nasal mask for obstructive sleep apnea in the United States.  

Irvine, California 15 April 2024 - Fisher & Paykel Healthcare Corporation Limited today announced the launch of the F&P Solo™ Nasal mask in the USA for the treatment of obstructive sleep apnea (OSA). 

The world’s first AutoFit™ mask, F&P Solo, simplifies setup like no other, enabling users to stretch the mask onto the face and adjust it with one touch.  

“We welcome the entrance of F&P Solo Nasal into the US and look forward to offering this mask to our customers and patients,” said Justin Callahan, VP Sales & Marketing for Fisher & Paykel Healthcare. 

 “F&P Solo Nasal marks the creation of our AutoFit segment, our teams have delivered a significant leap in mask innovation, driven by the unwavering commitment to enhance patient outcomes. The simplified setup and fit process makes it a valuable addition to our product lineup.” 

Without conventional straps or clips, the mask reduces overtightening on the face. AutoLock™ technology holds the mask in place with minimal force and dynamically responds to sleep movement and CPAP-therapy pressure. It’s intuitive, innovative, and first-of-a-kind. 

“Patients can set themselves up without assistance and then easily finetune the mask during nightly use for an optimal fit,” said Andrew Somervell, VP Products and Technology. “Our focus on what’s best for the patient led us here – we sought a result that optimizes for both comfort and simplicity, and we believe F&P Solo delivers on this.” 

The mask is supported by positive clinical trial results: 

• 95% of users can set themselves up without assistance1; and 

• 93% of patients rated their experience with the F&P Solo Nasal mask as simple or very simple2. 

F&P Solo Nasal comes with a nasal cushion, featuring dynamic support technology that allows freedom of movement, while keeping the cushion comfortably in place. The cushion is available in four sizes (small, medium, large, and wide), and one size for the headgear.  

F&P Solo simplifies the mask experience across the user’s journey. User-friendly packaging and the myMask™ App provide setup confidence and additional ongoing support if needed. http://www.fphcare.com/Solowww.fphcare.com/solo 

 

References 

1 40 out of 42 participants can set themselves up without assistance. Defined as orienting the mask on the head/face as intended and achieving an acceptable seal. Internal self-setup trial conducted with 45 participants, naïve to CPAP therapy, in New Zealand in 2022. 

2 42 out of 45 participants rated their experience with the F&P Solo Nasal mask as simple or very simple. Internal validation study conducted with 45 participants in the United States in 2022. 

 

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Media: Karen Knott GM Corporate Communications karen.knott@fphcare.co.nz +64 (0) 21 713 911   Investors: Dan Adolph Investor Relations Manager dan.adolph@fphcare.co.nz +64 (0) 22 511 4050